Genomic profiling of combined hepatocellular‐cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma
Nancy M. Joseph(University of California, San Francisco), Gregor Krings(Cleveland Clinic), Robin Kate Kelley(UCSF Helen Diller Family Comprehensive Cancer Center), Eric Talevich(University of California, San Francisco), Sarah E. Umetsu(University of California, San Francisco), Sarah Bowman(Harvard University), Christos G. Tsokos(Massachusetts General Hospital), Sanjay Kakar(University of California, San Francisco), Courtney Onodera(University of California, San Francisco), Linda D. Ferrell, A. Hunter Shain(University of California, San Francisco)
Cited by 121
Related Papers
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2021|6.6k
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
|The Lancet Oncology|2018|2.5k
Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact Survival
|Hepatology|2001|2.3k
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
|NEJM Evidence|2022|1.4k